You just read:

Sanofi and Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

Sanofi

Jun 04, 2017, 10:00 ET